CAMELLIA Cohort: A Longitudinal Study to Understand Sexual Health and Prevention Among Women in Alabama

Study acronym: CAMELLIA
StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Enrolling by Invitation → Active, Not Recruiting
    • Eligibility criteria expanded, about 9 words
  2. Re-verified, no change to tracked fieldsv8
  3. Eligibility criteria revisedv7
  4. Primary completion date: Jan 2028 to Aug 30, 2027
    • Study completion date: Jul 2028 to Aug 30, 2027
    • Start date: Nov 13, 2023 to Dec 12, 2023
    v6
  5. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 2023 to Nov 13, 2023
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Oct 2023 to Nov 2023v4
  2. Start date: Aug 2023 to Oct 2023v3
  3. Start date: Jan 2023 to Aug 2023
    • Eligibility criteria revised
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pre-exposure prophylaxis (PrEP) is an important biomedical human immunodeficiency virus (HIV) prevention tool and may particularly benefit black, cis and trans-gender women, who are at an increased risk for HIV and Sexually Transmitted Infections (STIs). The purpose of this study is to use a population-based approach to create a cohort of cis and trans-gender women at risk for future HIV acquisition to better understand the factors associated with the risk of STIs and HIV diagnosis and predictors of PrEP use.
Trial Details
NCT Number NCT05463692
Lead Sponsor University of Alabama at Birmingham
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions
(from sponsor)		 Hiv, Sexually Transmitted Diseases
Related terms Acquired Immunodeficiency Syndrome, Sexually Transmitted Diseases
Enrollment 830 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov